Syntropic is developing a non-invasive, light-based therapy that enhances neuroplasticity by activating immune cells in the brain to promote healing and cognitive function. This technology aims to provide a cost-effective, side effect-free alternative for individuals suffering from psychiatric disorders, addressing the limitations of traditional antidepressant treatments.
Funding
$1.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
TAFounders
Product
Problem
Existing antidepressant treatments often fall short, with over 50% of patients relapsing and over 30% receiving no benefit. These treatments primarily target neurotransmitter imbalances and may not address the underlying causes of psychiatric disorders, while also carrying the risk of side effects.
Solution
Syntropic is developing a non-invasive, non-pharmaceutical light-based therapy designed to enhance neuroplasticity and improve cognitive function in individuals with psychiatric disorders. The therapy uses light stimulation to instruct immune cells in the brain to support neural remodeling, addressing the underlying causes of mental health conditions. By activating microglia to remodel perineuronal nets, the technology promotes a juvenile-like neuroplasticity state, potentially offering long-lasting relief from psychiatric illness without the side effects associated with drug therapies. Clinical development is underway to deliver this technology as an accessible, affordable, and patient-friendly solution.
Target Audience
The primary target audience includes individuals suffering from psychiatric disorders, particularly those who have not found adequate relief from existing treatments or struggle with side effects, as well as healthcare systems seeking cost-effective and accessible mental health solutions.
Features
- Non-invasive light stimulation to modulate brain activity
- Targets immune cells (microglia) to promote neural remodeling
- Aims to reduce symptoms of depression and promote cognitive function
- Designed to be free of pharmaceuticals and associated side effects
- Focus on accessibility, affordability, and patient usability